Histogenics Corporation Announces Key Additions to Management Team  
8/20/2013 6:55:06 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Histogenics Corp., a late stage company developing novel tissue repair solutions initially targeting orthopedics, today announced the addition of two new members to its management team. Stephen Kennedy, previously with Genzyme, was added as Senior Vice President of Manufacturing, Operations, and Supply Chain, and Vladimir Scerbin, previously with Covidien, was added as Vice President of Clinical Affairs.

Hey, check out all the research scientist jobs. Post your resume today!